Latest Appointments

Steve Arnold joins UCB as MD for the British and Irish Isles

UCB has announced that Steve Arnold has joined UCB as managing director for the British and Irish Isles.

more info

FleishmanHillard hires two healthcare directors

FleishmanHillard London has added two directors to its healthcare leadership team: Robert Hanvik and Alison Wright have joined the agency to work on existing client accounts and support continued expansion.

more info

Former Weber Shandwick worker joins Porter Novelli

PR firm Porter Novelli has named Mary Smiddy as its new UK head of health and wellness.

more info

Alexion broadens senior team with new hires

Ultra-rare drug specialist Alexion Pharmaceuticals is broadening and strengthening its executive leadership with two new hires and a promotion.

more info

Former AstraZeneca man joins NKD Learning

Senior HR director Rob Cook has been appointed as the new operational managing director at learning and development agency NKD Learning, where he reports to chief executive and Founder Sue Stoneman.

more info

Four new members join Public Health England’s advisory board

Professor Richard Parish is one of the four new non-executive members on the Public Health England’s (PHE) Advisory Board.

more info

Immunocore takes on Eva-Lotta Allan to its Board

Immunocore, the Oxford-based biotech specialising in cancer and viral disease, has taken on Eva-Lotta Allan to the board as its chief business officer.

more info

Aeras names Dr Thomas Evans as new leader

The US TB vaccines specialist firm Aeras has appointed Dr Thomas Evans as its president and chief executive effective immediately.

more info

Paul Gittins becomes MD of Edelman UK Health and BioScience

Edelman has appointed Paul Gittins to the role of group managing director of Edelman UK’s Health and BioScience practice.

more info

Shield Therapeutics makes two senior appointments

Shield Therapeutics, the mineral medicines company, has two new appointments with Dr Lynn Drummond (pictured) joining the board as a non-executive director, and Dr Julian Howell joining the senior management team as group medical director and VP of drug development.

more info